A clinical experience report described successful procedures using a combined anesthesia strategy. It did not isolate midazolam’s effect or establish the absence of rare adverse events.
Children received ketamine and midazolam for sedation around spinal anesthesia with levobupivacaine. Additional midazolam boluses maintained sedation during the orthopedic procedures.
The authors reported stable pediatric vital signs, no intraoperative adverse events, and no conversion to general anesthesia. They also reported no postoperative dural-puncture headache, delirium, or nightmares in the series.
Spinal blockade, ketamine, midazolam, monitoring, and clinical selection all contributed to the observed care. This was an experience report from a resource-limited refugee-hospital setting rather than a randomized comparison.
The absence of an event in a series does not demonstrate zero risk or equivalent safety across settings. Forensic interpretation should reconstruct the complete sequence, actual doses, airway observations, and recovery record. The report does not support attributing every favorable outcome to midazolam or assuming the same results for a different patient or procedure.
Original analysis of the supplied journal article, identified as PMC3485388.